DeJesus OT - Search Results

1

Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.

Doudet DJ, Chan GL, Jivan S, DeJesus OT, McGeer EG, English C, Ruth TJ, Holden JE. Doudet DJ, et al. Among authors: dejesus ot. J Cereb Blood Flow Metab. 1999 Mar;19(3):278-87. doi: 10.1097/00004647-199903000-00006. J Cereb Blood Flow Metab. 1999. PMID: 10078880

2

Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.

Endres CJ, DeJesus OT, Uno H, Doudet DJ, Nickles JR, Holden JE. Endres CJ, et al. Among authors: dejesus ot. Front Biosci. 2004 Jan 1;9:505-12. doi: 10.2741/1224. Front Biosci. 2004. PMID: 14766386

3

Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.

DeJesus OT, Endres CJ, Shelton SE, Nickles RJ, Holden JE. DeJesus OT, et al. J Nucl Med. 1997 Apr;38(4):630-6. J Nucl Med. 1997. PMID: 9098215 Free article.

4

Fetal dopamine receptor characteristics assessed in utero.

Bartlett RM, Dejesus OT, Barnhart TE, Nickles RJ, Christian BT, Graner JL, Holden JE. Bartlett RM, et al. Among authors: dejesus ot. J Cereb Blood Flow Metab. 2010 Aug;30(8):1437-40. doi: 10.1038/jcbfm.2010.77. Epub 2010 Jun 9. J Cereb Blood Flow Metab. 2010. PMID: 20531464 Free PMC article.

5

A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease.

Gallagher CL, Christian BT, Holden JE, Dejesus OT, Nickles RJ, Buyan-Dent L, Bendlin BB, Harding SJ, Stone CK, Mueller B, Johnson SC. Gallagher CL, et al. Among authors: dejesus ot. Mov Disord. 2011 Sep;26(11):2032-8. doi: 10.1002/mds.23778. Epub 2011 Jun 2. Mov Disord. 2011. PMID: 21638324 Free PMC article.

6

Visualization of dopamine nerve terminals by positron tomography using [18F]fluoro-beta-fluoromethylene-m-tyrosine.

DeJesus OT, Holden JE, Endres C, Murali D, Oakes TR, Shelton S, Uno H, Houser D, Freund L, Perlman SB, et al. DeJesus OT, et al. Brain Res. 1992 Nov 27;597(1):151-4. doi: 10.1016/0006-8993(92)91518-j. Brain Res. 1992. PMID: 1477728

7

Evaluation of 3-[18F]fluoro-alpha-fluoromethyl-p-tyrosine as a tracer for striatal tyrosine hydroxylase activity.

DeJesus OT, Murali D, Kitchen R, Endres C, Oakes TR, Shelton SE, Freund L, Houser D, Uno H, Holden JE, et al. DeJesus OT, et al. Nucl Med Biol. 1994 May;21(4):663-7. doi: 10.1016/0969-8051(94)90033-7. Nucl Med Biol. 1994. PMID: 9234325

8

Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.

Brown WD, Oakes TR, DeJesus OT, Taylor MD, Roberts AD, Nickles RJ, Holden JE. Brown WD, et al. Among authors: dejesus ot. J Nucl Med. 1998 Nov;39(11):1884-91. J Nucl Med. 1998. PMID: 9829576 Free article.

9

Localization of trapping of 6-[(18)F]fluoro-L-m-tyrosine, an aromatic L-amino acid decarboxylase tracer for PET.

Brown WD, DeJesus OT, Pyzalski RW, Malischke L, Roberts AD, Shelton SE, Uno H, Houser WD, Nickles RJ, Holden JE. Brown WD, et al. Among authors: dejesus ot. Synapse. 1999 Nov;34(2):111-23. doi: 10.1002/(SICI)1098-2396(199911)34:2<111::AID-SYN4>3.0.CO;2-0. Synapse. 1999. PMID: 10502310

10

A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.

Li CT, Palotti M, Holden JE, Oh J, Okonkwo O, Christian BT, Bendlin BB, Buyan-Dent L, Harding SJ, Stone CK, DeJesus OT, Nickles RJ, Gallagher CL. Li CT, et al. Among authors: dejesus ot. Synapse. 2014 Aug;68(8):325-31. doi: 10.1002/syn.21745. Epub 2014 Apr 22. Synapse. 2014. PMID: 24710997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters